Dual Intravitreal Implantation of NT-501 Encapsulated Cell Therapy for Glaucoma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
To determine the safety and efficacy over 24 months of dual NT-501 CNTF encapsulated cell therapy (ECT) on visual impairment related to glaucoma.
Epistemonikos ID: 7b460ac493fba794a3df57505751ebe6ccfcf616
First added on: May 07, 2024